SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Myria Petrou, Ben A. Dwamena, Bradley R. Foerster, Mark P. MacEachern, Nicolaas I. Bohnen, Martijn LTM Müller, Roger L. Albin, Kirk A. Frey, Amyloid deposition in Parkinson's disease and cognitive impairment: A systematic review, Movement Disorders, 2015, 30, 7
  2. 2
    Paul Donaghy, Alan J. Thomas, John T. O'Brien, Amyloid PET Imaging in Lewy Body Disorders, The American Journal of Geriatric Psychiatry, 2015, 23, 1, 23

    CrossRef

  3. 3
    Ana M. Catafau, Santiago Bullich, Amyloid PET imaging: applications beyond Alzheimer’s disease, Clinical and Translational Imaging, 2015, 3, 1, 39

    CrossRef

  4. You have free access to this content4
    Yoshie Omachi, Kimiteru Ito, Kunimasa Arima, Hiroshi Matsuda, Yasuhiro Nakata, Masuhiro Sakata, Noriko Sato, Kazuyuki Nakagome, Nobutaka Motohashi, Clinical impact of 11C-Pittsburgh compound-B positron emission tomography carried out in addition to magnetic resonance imaging and single-photon emission computed tomography on the diagnosis of Alzheimer's disease in patients with dementia and mild cognitive impairment, Psychiatry and Clinical Neurosciences, 2015, 69, 12
  5. 5
    H. Shimada, S. Hirano, H. Sinotoh, T. Ota, N. Tanaka, K. Sato, M. Yamada, K. Fukushi, T. Irie, M. R. Zhang, M. Higuchi, S. Kuwabara, T. Suhara, Dementia with Lewy bodies can be well-differentiated from Alzheimer's disease by measurement of brain acetylcholinesterase activity—a [11C]MP4A PET study, International Journal of Geriatric Psychiatry, 2015, 30, 11
  6. 6
    Kirk A. Frey, Myria Petrou, Imaging amyloidopathy in Parkinson disease and parkinsonian dementia syndromes, Clinical and Translational Imaging, 2015, 3, 1, 57

    CrossRef

  7. 7
    Jung Han Yoon, Min Kim, So Young Moon, Seok Woo Yong, Ji Man Hong, Olfactory function and neuropsychological profile to differentiate dementia with Lewy bodies from Alzheimer's disease in patients with mild cognitive impairment: A 5-year follow-up study, Journal of the Neurological Sciences, 2015, 355, 1-2, 174

    CrossRef

  8. 8
    Kazunari Ishii, Chisa Hosokawa, Tomoko Hyodo, Kenta Sakaguchi, Kimio Usami, Kenji Shimamoto, Makoto Hosono, Yuzuru Yamazoe, Takamichi Murakami, Regional glucose metabolic reduction in dementia with Lewy bodies is independent of amyloid deposition, Annals of Nuclear Medicine, 2015, 29, 1, 78

    CrossRef

  9. 9
    A. Nordberg, Brain Mapping, 2015,

    CrossRef

  10. 10
    Campbell J Le Heron, Sarah L Wright, Tracy R Melzer, Daniel J Myall, Michael R MacAskill, Leslie Livingston, Ross J Keenan, Richard Watts, John C Dalrymple-Alford, Tim J Anderson, Comparing cerebral perfusion in Alzheimer’s disease and Parkinson’s disease dementia: an ASL-MRI study, Journal of Cerebral Blood Flow & Metabolism, 2014, 34, 6, 964

    CrossRef

  11. 11
    Stephen N. Gomperts, Imaging the Role of Amyloid in PD Dementia and Dementia with Lewy Bodies, Current Neurology and Neuroscience Reports, 2014, 14, 8

    CrossRef

  12. 12
    K. Ishii, PET Approaches for Diagnosis of Dementia, American Journal of Neuroradiology, 2014, 35, 11, 2030

    CrossRef

  13. 13
    Philipp T. Meyer, Lars Frings, Sabine Hellwig, Update on SPECT and PET in parkinsonism – part 2, Current Opinion in Neurology, 2014, 27, 4, 398

    CrossRef

  14. 14
    Andrea Ciarmiello, Chiara Gaeta, Claudio Guidotti, Massimo del Sette, Multiagent imaging of the brain, Clinical and Translational Imaging, 2013, 1, 6, 365

    CrossRef

  15. 15
    Shuo Zhang, Nadja Smailagic, Chris Hyde, Anna H Noel-Storr, Yemisi Takwoingi, Rupert McShane, Juan Feng, 11C-PIB-PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI), The Cochrane Library,